Did you get a response You can mix as much, (or as little) water as your vial will hold
Research-grade specs Class: Small-molecule NNMT inhibitor (not a peptide) Molecular weight: 177 g/mol Vial size: 50 mg Format: Lyophilized powder Mechanism studied: NNMT inhibition and intracellular NAD availability This compound is manufactured under cGMP conditions in Dallas, Texas, and independently verified to 99% purity through HPLC and mass spectrometry analysis, with a batch-specific Certificate of Analysis provided for every order
Researchers who require documentation of purity, manufacturing origin, and testing methodology will find this information included with every order
Enhanced angiogenesis is a key feature of the Wolverine Stack in combined pre-clinical studies
BPC-157's first controlled human trial (NCT07437547) only began in 2026, with results expected around 2027
Peptide Research: A Paradigm Shift It's useful to see how the research focus of a compound like BPC-157 differs from the standard-of-care treatments currently available